Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
NovoCure Ltd.
NovoCure Ltd.
Novartis
Merck Sharp & Dohme LLC
Pharmacyclics LLC.
SWOG Cancer Research Network
NRG Oncology
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Ipsen
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
Radiation Therapy Oncology Group
Heron Therapeutics
AstraZeneca
Takeda
Pfizer
Daiichi Sankyo
Bayer
Gamida Cell ltd
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Seagen Inc.
Bayer
National Cancer Institute (NCI)
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Bristol-Myers Squibb
Dana-Farber Cancer Institute
AstraZeneca
Amgen
Hoffmann-La Roche
Sanofi
Merck Sharp & Dohme LLC
ETOP IBCSG Partners Foundation
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Novartis
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
EMD Serono